News Hub

Cytotherapy 2021 Impact Factor Just Released

  

 

 
ISCT is pleased to announce the 2021 Impact Factor for CYTOTHERAPY®.

 

Thank you to all those that have contributed to the continued growth of the Society's peer reviewed journal.

Cytotherapy provides a platform to disseminate CGT translation research globally and we invite you to when ready for publication.

 

We are currently recruiting manuscripts in gene therapy, immunotherapy, EV and MSC research, regulatory frameworks and policy issues, and advances in CGT product manufacturing, commercialization, and patient access.

 

- Donald G. Phinney, PhD, Cytotherapy Senior Editor

 


Donald G. Phinney, PhD

Cytotherapy Senior Editor 


Patrick Hanley, PhD
Cytotherapy Commissioning Editor

 

Associate Editors

Oscar Lee, MD, PhD

Luis A. Ortiz, MD

Anna Pasetto, PhD

Qasim A. Rafiq, PhD

Sowmya Viswanathan, PhD

 

Assistant Editor
Rachel A. Burga, PhD

ISCT Head Office Liaison
Felix Grignon, MA


#CytotherapyCorner

0 comments
9 views

Permalink